The effect of glucagon on spontaneous contractility of isolated pregnant uterine muscle

Obstetrics and Gynecology

Volumn 88, Issue 5, 1996, Pages 867-871

  Shin, Young K ^b   Collea, Joseph V ^a   Kim, Young D ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; PANCREAS HORMONE; UTERUS SPASMOLYTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; GLUCAGON RELEASE; HUMAN; PREGNANCY; PRIORITY JOURNAL; UTERUS CONTRACTILITY; UTERUS RELAXATION;

EID: 0030296393     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00283-9     Document Type: Article

References (19)

1. 1. Taylor I, Duthie HL, Cumberland DC, Smallwood R. Glucagon and the colon. Gut 1975;16:973-8.
2. 2. Ferrucci JT, Wittenberg J, Stone LB, Dreyfuss JR. Hypotonic cholangiography with glucagon. Radiology 1976;118:466-7.
3. 3. Ponce J, Garrigues V, Pertejo V, Sala T, Lazaro MJ, Del Val A, et al. Effect of intravenous glucagon and glucagon-(1-21)-peptide on motor activity of sphincter of Oddi in humans. Dig Dis Sci 1989;34:61-4.
4. 4. Winfield AC, Pittaway D, Maxson W, Daniell J, Wentz AC. Apparent cornual occlusion in hysterosalpingography: Reversal by glucagon. Am J Roentgenol 1982;139:525-7.
5. 5. Ansari AH, Shimoura H. Hypotonic hysterosalpingography with glucagon. Fertil Steril 1978:30:476-7.
6. 6. Benedetti TJ. Maternal complications of parenteral β-sympathomimetic therapy for premature labor. Am J Obstet Gynecol 1983;145: 1-6.
7. 7. Parmley WW, Glick G, Sonnenblick EH. Cardiovascular effects of glucagon in man. N Engl J Med 1968;279:12-7.
8. 8. Rayburn W, Piehl E, Sanfield J, Compton A. Reversing severe hypoglycemia during pregnancy with glucagon therapy. Am J Perinatol 1987;4:259-61.
9. 9. Leroy MJ, Tanguy G, Vial M, Rostène W, Malassiné A, Ferré F. The effect of vasoactive intestinal peptide (VIP) on the contractile activity of human uterine smooth muscle. Clin Exp Pharmacol Physiol 1991;18:205-15.
10. 10. Hansen LH, Abrahamsen N, Nishimura E. Glucagon receptor mRNA distribution in rat tissues. Peptides 1995;16:1163-6.
11. 11. Klein I, Levey GS, Fletcher MA. Glucagon binding and adenylate cyclase: Evidence for a dissociable receptor site. J Clin Invest 1974;53:40a.
12. 12. Farah AE. Glucagon and the circulation. Pharmacol Rev 1983;35: 181-217.
13. 13. Sarcione EJ, Back N, Sokal JE, Mehlman B, Knoblock E. Elevation of plasma epinephrine levels produced by glucagon in vivo. Endocrinology 1963;72:523-6.
14. 14. Craft JB, Epstein BS, Coakley CS. Effect of lidocaine with epinephrine versus lidocaine (plain) on induced labor. Anesth Analg 1972;51:243-6.
15. 15. Ottesen B, Ulrichsen H, Fahrenkrug J, Larsen JJ, Wagner G, Schierup L, et al. Vasoactive intestinal polypeptide and the female genital tract: Relationship to reproductive phase and delivery. Am J Obstet Gynecol 1982;143:414-20.
16. 16. Takeda K, Lowry LD, Liu JJC. Effect of urea, glycerol, and mannitol on basilar and labyrinthine arteries. Otolaryngol Head Neck Surg 1988;98:226-30.
17. 17. Shin YK, Kim YD, Collea JV, Belcher MD. Effect of dantrolene sodium on contractility of isolated human uterine muscle. Int J Obstet Anesth 1995;4:197-200.
18. 18. Ogata N, Toyoda M, Shibata T. Suppression of intestinal smooth muscle contraction by phenolic compounds. Res Commun Chem Pathol Pharmacol 1992;77:359-66.
19. 19. Lee JC, Downing SE. Negative inotropic effects of phenol on isolated cardiac muscle. Am J Pathol 1981;102:367-72.